Support poured in for a suburban police officer, who is a father of five boys, as he battled cancer and had to have his foot amputated.
Adaptimmune is rolling out its T cell therapy Tecelra for synovial sarcoma, recording $1.2 million in sales since its ...
Despite scoring a historic FDA approval last year, Adaptimmune Therapeutics is expressing concerns about its own longevity, ...
PHILADELPHIA, PA — The Synovial Sarcoma Foundation, in partnership with Children’s Hospital of Philadelphia (CHOP) and Penn ...
Multiple presentations demonstrate that T-knife’s proprietary next-generation technologies address important challenges with ...